Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Treeline Biosciences, Inc.

Clinical trials sponsored by Treeline Biosciences, Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New pill takes on tough lymphoma: early trial seeks tumor shrinkage Results expected Nov 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

New pill takes on tough lymphoma: early trial seeks tumor shrinkage

Disease control Ongoing

This early-phase trial tests an oral drug called TLN-254 in about 50 adults with relapsed or refractory T-cell lymphoma. The main goal is to see if the drug can shrink tumors and how safe it is. Participants take the drug by mouth on a set schedule, and researchers will monitor r…

Phase 1 • Sponsor: Treeline Biosciences, Inc. • Aim: Disease control

Last updated Aug 20, 2026 00:00 UTC